DIS
68
4
BRK.B
40
4
BAX
48
4
BLK
64
3
AZO
43
3
CNX
59
-4
AVY
53
6
AES
57
2
BEN
52
2
ALLE
50
9
ADP
64
5
AXP
74
3
APD
44
9
AAL
51
-2
CME
48
6
AIZ
59
5
AA
72
3
AMZN
53
-2
CINF
60
3
BBY
48
2
DIS
68
4
BRK.B
40
4
BAX
48
4
BLK
64
3
AZO
43
3
CNX
59
-4
AVY
53
6
AES
57
2
BEN
52
2
ALLE
50
9
ADP
64
5
AXP
74
3
APD
44
9
AAL
51
-2
CME
48
6
AIZ
59
5
AA
72
3
AMZN
53
-2
CINF
60
3
BBY
48
2
Financhill
Back

Salesforce, Inc. Vs. Stoke Therapeutics, Inc. Industry Stock Comparison

Buy
59

CRM
Salesforce, Inc.

Last Price:
$262.30
Seasonality Move:
6.5%
Buy
66

STOK
Stoke Therapeutics, Inc.

Last Price:
$33.08
Seasonality Move:
1.4%
Buy
59
Salesforce, Inc. (CRM) is a Buy

Is Salesforce, Inc. a Buy, Sell or Hold?

  • The current Salesforce, Inc. [CRM] share price is $262.35. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Stoke Therapeutics, Inc. (STOK) is a Buy

Is Stoke Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Stoke Therapeutics, Inc. [STOK] share price is $33.09. The Score for STOK is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CRM Stock Price Chart

What is Salesforce, Inc.'s stock price today?

  • The Salesforce, Inc. share price today is $262.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing selling pressure, which indicates risk of future bearish movement.

STOK Stock Price Chart

What is Stoke Therapeutics, Inc.'s stock price today?

  • The Stoke Therapeutics, Inc. share price today is $33.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing selling pressure, which indicates risk of future bearish movement.

CRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.66 Buy
Relative Strength Index (14 RSI): 65.73 Buy
Chaikin Money Flow: -4334029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (229.22 - 252.98) Buy
Bollinger Bands (100): (236.45 - 256.93) Buy

STOK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.29 Buy
Relative Strength Index (14 RSI): 60.05 Buy
Chaikin Money Flow: -924088 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.5 - 31.94) Buy
Bollinger Bands (100): (17.56 - 30.8) Buy

CRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 253.57 Buy
20-day SMA: 240.8 Buy
50-day SMA: 245.29 Buy
200-day SMA: 258.54 Buy
8-day EMA: 254.78 Buy
20-day EMA: 247.12 Buy
50-day EMA: 245.71 Buy
200-day EMA: 258.86 Buy

STOK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.68 Buy
20-day SMA: 30 Buy
50-day SMA: 29.59 Buy
200-day SMA: 16.86 Buy
8-day EMA: 31.92 Buy
20-day EMA: 30.46 Buy
50-day EMA: 28.38 Buy
200-day EMA: 20.14 Buy

Salesforce, Inc. Earnings Growth & CRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.20 per share, an increase this year of $1.83 per share, and an increase next year of $1.75 per share.

Stoke Therapeutics, Inc. Earnings Growth & STOK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $3.13 per share.

Salesforce, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Stoke Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):